Monday, December 19, 2016

BRIEF-Theravance biopharma highlights initiation of Phase 3 study

* Theravance Biopharma highlights initiation of phase 3

study of the closed triple in patients with asthma by

glaxosmithkline and innoviva

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)